You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Chemotherapy Induced Neutropenia Drug Market Study 2016-2026, by Segment (F-627, BBT-018, … …), by Market (Hospital, Clinic, … …), by Company (BeyondSpring Pharmaceuticals Inc, Biocon Ltd, … …)

Summary

The global Chemotherapy Induced Neutropenia Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
F-627
BBT-018
Filgrastim
GW-003
NLA-101
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Others
Company Coverage (Sales data, Main Products & Services etc.):
BeyondSpring Pharmaceuticals Inc
Biocon Ltd
Bolder Biotechnology Inc
Cellerant Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Cinfa Biotech SL
Dr. Reddy's Laboratories Ltd
Gene Techno Science Co Ltd
Generon (Shanghai) Corp Ltd
Genexine Inc
GlycoMimetics Inc
Hanmi Pharmaceuticals Co Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Mycenax Biotech Inc
Myelo Therapeutics GmbH
Nohla Therapeutics Inc
Octapharma AG
Pangen Biotech Inc.
Pfenex Inc
Pfizer Inc
Reliance Life Sciences Pvt Ltd
Richter Gedeon Nyrt
Sandoz International GmbH
USV Pvt Ltd
Major Region Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa
Table of Content
1 Industry Overview
1.1 Chemotherapy Induced Neutropenia Drug Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 Chemotherapy Induced Neutropenia Drug Market by Type
2.1 By Type
2.1.1 F-627
2.1.2 BBT-018
2.1.3 Filgrastim
2.1.4 GW-003
2.1.5 NLA-101
2.1.6 Others
2.2 Market Size by Type
2.3 Market Forecast by Type
3 Global Market Demand
3.1 Segment Overview
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 Major Region Market
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 Major Companies List
5.1 BeyondSpring Pharmaceuticals Inc (Company Profile, Sales Data etc.)
5.2 Biocon Ltd (Company Profile, Sales Data etc.)
5.3 Bolder Biotechnology Inc (Company Profile, Sales Data etc.)
5.4 Cellerant Therapeutics Inc (Company Profile, Sales Data etc.)
5.5 Chong Kun Dang Pharmaceutical Corp (Company Profile, Sales Data etc.)
5.6 Cinfa Biotech SL (Company Profile, Sales Data etc.)
5.7 Dr. Reddy's Laboratories Ltd (Company Profile, Sales Data etc.)
5.8 Gene Techno Science Co Ltd (Company Profile, Sales Data etc.)
5.9 Generon (Shanghai) Corp Ltd (Company Profile, Sales Data etc.)
5.10 Genexine Inc (Company Profile, Sales Data etc.)
5.11 GlycoMimetics Inc (Company Profile, Sales Data etc.)
5.12 Hanmi Pharmaceuticals Co Ltd (Company Profile, Sales Data etc.)
5.13 Intas Pharmaceuticals Ltd (Company Profile, Sales Data etc.)
5.14 Lupin Ltd (Company Profile, Sales Data etc.)
5.15 Mycenax Biotech Inc (Company Profile, Sales Data etc.)
5.16 Myelo Therapeutics GmbH (Company Profile, Sales Data etc.)
5.17 Nohla Therapeutics Inc (Company Profile, Sales Data etc.)
5.18 Octapharma AG (Company Profile, Sales Data etc.)
5.19 Pangen Biotech Inc. (Company Profile, Sales Data etc.)
5.20 Pfenex Inc (Company Profile, Sales Data etc.)
5.21 Pfizer Inc (Company Profile, Sales Data etc.)
5.22 Reliance Life Sciences Pvt Ltd (Company Profile, Sales Data etc.)
5.23 Richter Gedeon Nyrt (Company Profile, Sales Data etc.)
5.24 Sandoz International GmbH (Company Profile, Sales Data etc.)
5.25 USV Pvt Ltd (Company Profile, Sales Data etc.)
6 Conclusion